Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock

Nephron

Volumn 74, Issue 2, 1996, Pages 431-432

  Allegra, Alessandro ^b   Galasso, Anselmo ^c   Corica, Francesco ^b,d   Aloisi, Carmela ^a   Frisina, Nicola ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Medical Pathology I   (Italy)

^c Medical Pathology I   (Italy)

^d Polyclinic   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; DOBUTAMINE; DOPAMINE; GELATIN; NORMOSOL; RECOMBINANT ERYTHROPOIETIN;

ADULT; BLOOD OXYGEN TENSION; CENTRAL VENOUS PRESSURE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INDEX; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HYPOVOLEMIC SHOCK; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

DOBUTAMINE; DOPAMINE; ERYTHROPOIETIN; FATAL OUTCOME; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; PULMONARY ARTERY; RECOMBINANT PROTEINS; SHOCK; VASCULAR RESISTANCE;

EID: 0029834572     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189352     Document Type: Article

References (12)

1. Kilbourn RG. Belloni P: Endothelial cells production of nitrogen oxides in response to IFN in combination withTNF. IL-I or endotoxin. J Rep 1990:82:772.
2. Kilbourn RG. Gross SS. Lodato RF. etal: Inhibition of interleukin-1-alpha-induced nitric oxide synthetase in vascular smooth muscle and full reversal of intcrleukin-l-alpha-induced hypotension by N-to-amino-E-argininc. J Natl Cancer Inst 1992:84:1008.
3. Rockett K. Awbum MA. Aggarwal BB: In vivo induction of nitrite/nitratcbyTNF. LT and IL.-I: Roles in malaria. Infect Imnuin 1992:60: 3725-3730.
4. Hibbs JB, W'cstenfclder C. Taintor R: Evidence for cytokine-inducible nitric oxide synthesis from E-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992,89:867-877.
5. Tuttle RS. Boppana DP: Anti-hypertensive effect of intcrleukin-2 immunotherapy. A possible mechanism for the vascular leak syndrome. J Immunol 1987;139:1883-1888.
6. Sanchez-Crcspo M, Alonso F. Inarrea P. Alvarez V. Egido J: Vascular actions of a synthetic platelet-activating factor in the rat: Evidence for a platelet-independent mechanism. Imrnu-nopharntacology 1982:4:173-185.
7. Koniura I. Kurvhara H, Sugiyama T, Yoshizu-mi M. Takaku F, Yazaki Y: Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-252.
8. Buemi M, Allegra A. Marino D: Eritropoietina ricombinantc cd ipertensione arteriosa. Ital Nefrol 1990:8:155-160.
9. Buemi M. Dcnuzzo G. Allegra A. Aloisi C, Squadrito F. Squadrito G, Dattola A, Corica F, Vcmiiglio G: Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine. Int.J Microcirc, in press.
10. Buemi M. Allegra A. Squadrito F: Effects of intravenous administration of rHuEPO in rats to haemorrhagic shock. Nephron 1993:65:440- 443.
11. Tracey KJ. Lowry SF. Cerami A: Cachectin: a hormone that triggers acute shock and chronic cachexia. J Infect Dis 1988:157:413.
12. Hosford D. Paubert-Braquet M. Braquet P: Platelet-activating factor and cytokine interactions in shock. Resuscitation 1989; 18:7-18.